NCT07101523 Using Technologies to Promote HEalthy Lifestyles in Adolescents With Intellectual Disabilities
| NCT ID | NCT07101523 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Seville |
| Condition | Intellectual Disabilities (F70-F79) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-01-01 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
IDHEApp will implement various educational technology tools and work with the families, teachers and caregivers to increase physical activity (PA) and improve healthy eating. Due to the current COVID-19 pandemic restrictions, the use of innovative digital technology can contribute not just to distance learning but also to support families and students in remote. However, both healthy habits and technologies are insufficiently addressed in the population with IDD. These needs are in line with the following objectives of the Erasmus+ programme: a) Inclusion and diversity in all fields of education, training, youth and sport; b) Addressing digital transformation through development of digital readiness, resilience and capacity, and c) Encouraging the participation in sport and physical activity. Educators will find innovative possibilities and the right instruments that will enable them to fulfil their potential through innovative online education \& learning \& training skills module for lifestyle promotion and others available on the app. Furthermore, mentors and others health professionals (e.g., nursing etc.) will be equipped with knowledge and skills on how to use the app to teach practical skills for PA enhancement in an evidence-based way. Consequently, this project will contribute to \[specific objectives - SO\]: \- Raise awareness of the importance of healthy and active living among young Europeans with intellectual disabilities. Different workshops and bigger events (i.e., international conference), together with the involvement of numerous participants from the institutions of this consortium will be ensured. Further, a sensitized community will participate through the social networks and the website itself, in the proposed activities. \- Provide digital resources and tools to the partner entities of the exchange to improve lifestyle of young people with intellectual disabilities. Best Practices to provide high quality, inclusive digital health education with the best educational technology tools and methodology. A website, a mobile app and different electronic guidelines will be delivered. \- Analyze the current state of use and acceptance of technologies as support in the management of health in adolescent with intellectual disabilities.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of intellectual disability * Being able to follow basic instructions * Age between 4-30 years old Exclusion Criteria: * presence of severe sensory or motor impairments * medical conditions that contraindicated moderate physical activity * unable to access an smartphone during the intervention
Contact & Investigator
Borja Sañudo, PhD
PRINCIPAL INVESTIGATOR
University pof Seville
Frequently Asked Questions
Who can join the NCT07101523 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 30 Years, studying Intellectual Disabilities (F70-F79). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07101523 currently recruiting?
Yes, NCT07101523 is actively recruiting participants. Contact the research team at bsancor@us.es for enrollment information.
Where is the NCT07101523 trial being conducted?
This trial is being conducted at Seville, Spain.
Who is sponsoring the NCT07101523 clinical trial?
NCT07101523 is sponsored by University of Seville. The principal investigator is Borja Sañudo, PhD at University pof Seville. The trial plans to enroll 60 participants.